Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;142(2):364-381.
doi: 10.1016/j.jid.2021.06.033. Epub 2021 Aug 2.

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review

Affiliations

Differences in Psychometric Properties of Clinician- and Patient-Reported Outcome Measures for Atopic Dermatitis by Race and Skin Tone: A Systematic Review

Trisha Kaundinya et al. J Invest Dermatol. 2022 Feb.

Abstract

The psychometric validity and reliability of widely used atopic dermatitis (AD) outcome measures across different races and ethnicities are unclear. We describe the rates of reporting race, ethnicity, and skin tone in studies testing the psychometric properties of AD outcome measures and compare the psychometric analyses across race, ethnicity, and skin tone. We systematically reviewed MEDLINE and EMBASE for studies reporting psychometric properties of clinician-reported or patient-reported outcome measures in AD (International Prospective Register of Systematic Reviews: CRD42021239614). Overall, 16,100 nonduplicate articles were screened; 165 met inclusion criteria. Race and/or ethnicity were reported in 55 (33.3%) studies; of those, race was assessed by self-report in 10 studies (6.1%) or was unspecified in 45 (27.3%). A total of 16 studies (9.7%) evaluated psychometric property differences by race, and only five (4.4%) of those did not recognize it as a limitation. Properties assessed across race, ethnicity, or skin tone were differential item functioning, convergent validity feasibility, inter-rater reliability, intrarater reliability, test‒retest reliability, and known-groups validity. Multiple instruments demonstrated performance differences across ethnoracial groups. This review highlights the paucity of race/ethnicity consideration for psychometric property testing in AD outcome measurement instruments. More AD outcomes instruments should be validated in diverse populations.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

Dr. Thyssen has been an advisor, Investigator and Speaker for Abbvie, Pfizer, LEO Pharma, Sanofi-Genzyme, Eli Lilly & Co and Regeneron. He has received grants from Sanofi-Genzyme and Regeneron.

Dr. Alexis declares Grants (funds to institution) - Leo, Novartis, Almirall, Bristol-Myers-Squibb, Amgen, Menlo, Galderma, Valeant (Bausch Health), Cara, Arcutis. Consultant/Advisory Board - Leo, Galderma, Pfizer, Sanofi-Regeneron, Dermavant, Beiersdorf, Valeant, L’Oreal, BMS, Bausch health , UCB, Vyne , Arcutis, Janssen, Allergan, Almirall, Abbvie, Sol-Gel, Amgen. Speaker - Regeneron, SANOFI-Genzyme, Pfizer, Astra Zeneca

The remaining authors state no conflict of interest.

Figures

Figure 1.
Figure 1.
PRISMA flow diagram.

Similar articles

Cited by

References

    1. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993;186(1):23–31. - PubMed
    1. EASI for clinical signs. HOME For Eczema: HOME For Eczema; 2017.
    1. Al-Buainain H, Kholoud A, Mahmoud M, Allam M. Correlation between Quality of Life and Disease Severity in Children with Atopic Dermatitis in the State of Qatar. Panarab J;20.
    1. Al Shobaili HA. The impact of childhood atopic dermatitis on the patients' family. Pediatr Dermatol;27(6):618–23. - PubMed
    1. Alzolibani A Impact of atopic dermatitis on the quality of life of Saudi children. Saudi medical journal 2014;35(4):391–6. - PubMed

Publication types

MeSH terms

LinkOut - more resources